Vimarsana
Biggest News Aggregation in the World

Page 6 - First Author News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from First Author. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In First Author Today - Breaking & Trending Today

Too much insulin can be deadly as too little: Study - Vimarsana News

Too much insulin can be deadly as too little: Study

Insulin is an essential treatment for type 1 diabetes and often for type 2 diabetes, as well. Roughly 8.4 million Americans use insulin, according to the Americ

New deep learning AI model can help screen for retinopathy of prematurity in infants - Vimarsana News

New deep learning AI model can help screen for retinopathy of prematurity in infants

The team developed a deep learning AI model that can identify which at-risk infants have ROP that may lead to blindness if left untreated, and they hope their technique could improve access to screening in the many areas with limited neonatal services and few trained ophthalmologists.

Many top-selling brand-name drugs in Medicare may provide little added therapeutic benefit - Vimarsana News

Many top-selling brand-name drugs in Medicare may provide little added therapeutic benefit

Brand-name drugs cost two to three times more in the U.S. than in other countries, but many of the top-selling brand name drugs may provide little added therapeutic benefit.

New tool provides insight into the developmental history of certain immune cells - Vimarsana News

New tool provides insight into the developmental history of certain immune cells

A new tool that can uncover the developmental history of certain immune cells is now freely available worldwide. The tool provides insights into the stages that immune cells go through in a healthy individual and how this can be impacted in disease.

ChatGPT can help empower patients and improve health literacy for different populations - Vimarsana News

ChatGPT can help empower patients and improve health literacy for different populations

A new study by Cedars-Sinai investigators describes how ChatGPT, an artificial intelligence (AI) chatbot, may help improve health outcomes for patients with cirrhosis and liver cancer by providing easy-to-understand information about basic knowledge, lifestyle and treatments for these conditions.